Skip to content
lifestyle.spaziotribu.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
Legend Biotech USA Inc.
Legend Biotech Announces Late-Breaking Oral Presentation at EHA 2026 Showcasing Initial Phase 1 In Vivo CAR-T Data with LB2501 in Non-Hodgkin Lymphoma (NHL)
June 2, 2026
Legend Biotech Presents First-in-Human LB2102 Results in Solid Tumors and New CARVYKTI® Data in Multiple Myeloma at ASCO 2026
June 1, 2026
Legend Biotech Announces Presentations at ASCO 2026
May 21, 2026
Legend Biotech Reports First Quarter 2026 Results and Recent Highlights
May 12, 2026
Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth
May 4, 2026
Legend Biotech to Host Investor Conference Call on First Quarter 2026 Results
April 28, 2026